ABSTRACT
Coronavirus Disease (COVID-19) is an infectious disease that has a high fatality rate and is spreading quickly throughout the world. The WHO claims that SARS-CoV-2, a brandnew coronavirus strain, is to blame for this outbreak (Severe Acute Respiratory Syndrome Corona Virus-2) and that COVID-19 must be treated with both conventional medical therapy and a combination of modern medicine. The technique of this study, a review of the literature, focused on numerous investigations looking at the potential of curcumin molecules from turmeric to cure the COVID-19 disease. Primary data for scientific papers is gathered from national and international journals through searches on electronic search engines like Google Scholar, Sciencedirect, or PubMed and selected publications are assessed, evaluated, and interpreted by authors. Turmeric contains substances that are immune system boosters, anti-inflammatory, antitumor, antiviral, and antioxidants. Curcumin may prevent a number of viral infections, according to evidence. In vitro testing has shown that the SARS-CoV virus is resistant to curcumin's antiviral properties. It's possible that curcumin can halt viral replication. Curcumin has the potential to treat COVID-19 effectively. Curcumin has antiviral activity that can fight the SARS-CoV-two virus. Treatment with curcumin can change the virus top protein structure, preventing the virus from entering the body and from budding. Future study on the use of curcumin as SARS-Cov-2 virus inhibitory agent is necessary in order to employ it as a novel and long-lasting therapy option for Covid-19 patients. © 2022 WITPress. All rights reserved.
ABSTRACT
The inflationary illness caused by extreme acute respiratory syndrome coronavirus in 2019 (COVID-19) is an infectious and deadly disease. COVID-19 was first found in Wuhan, China, in December 2019, and has since spread worldwide. Globally, there have been more than 198 M cases and over 4.22 M deaths, as of the first of Augest, 2021. Therefore, an automated and fast diagnosis system needs to be introduced as a simple, alternative diagnosis choice to avoid the spread of COVID-19. The main contributions of this research are 1) the COVID-19 Period Detection System (CPDS), that used to detect the symptoms periods or classes, i.e., healthy period, which mean the no COVID19, the period of the first six days of symptoms (i.e., COVID-19 positive cases from day 1 to day 6), and the third period of infection more than six days of symptoms (i.e., COVID-19 positive cases from day 6 and more): 2) the COVID19 Detection System (CDS) that used to determine if the X-ray images normal, i.e., healthy case or infected, i.e., COVID-19 positive cases;3) the collection of database consists of three different categories or groups based on the basis of time interval of offset of Symptoms. For CPDS, the VGG-19 perform to 96% accuracy, 90% Fl score, 91% average precision, and 91% average recall. For CDS, the VGG-19 perform to 100% accuracy, 99% F1 score, 100% average precision, and 99% average recall.